What is the ICD‑10‑CM code for a tender erythematous nodule in the right hypochondriac region (located inferior to the right breast)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10-CM Code for Tender Erythematous Nodule in Right Hypochondriac Region

The appropriate ICD-10-CM code for a tender erythematous nodule in the right hypochondriac region (inferior to the right breast) depends on the underlying diagnosis, but without a confirmed etiology, use R22.1 (localized swelling, mass and lump, trunk) with laterality specification, or L98.9 (disorder of the skin and subcutaneous tissue, unspecified) if the lesion is clearly cutaneous.

Clinical Context and Differential Diagnosis

The location described—right hypochondriac region inferior to the breast—requires careful consideration of several potential diagnoses that would determine the specific ICD-10-CM code:

Key Diagnostic Considerations:

Erythema Nodosum (L52):

  • Characterized by raised, tender, red or violet subcutaneous nodules of 1-5 cm diameter 1
  • Commonly affects extensor surfaces but can occur on the trunk
  • Represents a focal panniculitis
  • If this is the confirmed diagnosis, use L52

Subcutaneous Nodule - Sarcoidosis (D86.3):

  • Subcutaneous nodules are listed as a probable clinical feature of sarcoidosis 2
  • If sarcoidosis is suspected or confirmed, use D86.3 (sarcoidosis of skin)

Skin Lesions - Other Systemic Conditions:

  • Maculopapular, erythematous lesions can occur in various conditions 2
  • Histiocytic disorders may present with red-brown nodules 3

Breast-Related Pathology:

  • While the location is inferior to the breast, skin changes around the breast require evaluation 4
  • If there's any concern for inflammatory breast cancer or breast-related pathology, imaging is mandatory before coding

Coding Algorithm

Step 1: Determine if diagnosis is confirmed

  • Confirmed diagnosis → Use specific disease code (e.g., L52 for erythema nodosum, D86.3 for cutaneous sarcoidosis)
  • Unconfirmed diagnosis → Proceed to Step 2

Step 2: Characterize the lesion anatomically

  • Clearly cutaneous/dermatologic → L98.9 (disorder of skin and subcutaneous tissue, unspecified) or L98.8 (other specified disorders of skin and subcutaneous tissue)
  • Deeper soft tissue involvement → R22.1 (localized swelling, mass and lump, trunk)

Step 3: Add laterality when possible

  • The right-sided location should be documented in clinical notes
  • Some codes allow laterality specification; use when available

Common Pitfalls

  • Do not use breast-specific codes (N60-N64 series) unless the nodule is clearly within breast tissue itself
  • Avoid premature specific coding without tissue diagnosis if malignancy is in the differential
  • Do not use "unspecified" codes if you have performed imaging or biopsy that provides more specific information
  • Remember that ICD-10-CM requires greater specificity than ICD-9-CM, with laterality and anatomic detail built into many codes 5

Clinical Workup Implications

Before finalizing the code, the clinical evaluation should include:

  • Imaging assessment if any concern for breast pathology (bilateral diagnostic mammogram ± ultrasound) 4
  • Biopsy consideration for persistent, suspicious, or enlarging lesions
  • Assessment for systemic disease (inflammatory markers, chest imaging if sarcoidosis suspected) 2

The final ICD-10-CM code should reflect the most specific diagnosis available at the time of coding, and may need to be updated as additional diagnostic information becomes available.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.